Prognostic value of histopathological DCIS features in a large-scale international interrater reliability study

Emma J. Groen, Jan Hudecek, Lennart Mulder, Maartje van Seijen, Mathilde M. Almekinders, Stoyan Alexov, Aniko Kovacs, Ales Ryska, Zsuzsanna Varga, Francisco-Javier Andreu Navarro, Simonetta Bianchi, Willem Vreuls, Eva Balslev, Max Boot, Janina Kulka, Ewa Chmielik, Ellis Barbe, Mathilda J. de Rooij, Winand Vos, Andrea FarkasNatalja E. Leeuwis-Fedorovich, Peter Regitnig, Pieter J. Westenend, Loes F. S. Kooreman, Cecily Quinn, Giuseppe Floris, Gabor Cserni, Paul J. van Diest, Esther H. Lips, Michael Schaapveld, Jelle Wesseling*, Grand Challenge PRECISION consortium

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)759-770
Number of pages12
JournalBreast Cancer Research and Treatment
Volume183
Issue number3
DOIs
Publication statusPublished - Oct 2020

Keywords

  • Ductal carcinoma in situ
  • Invasive breast cancer
  • Interrater reliability
  • Risk stratification
  • CARCINOMA-IN-SITU
  • INVASIVE BREAST-CANCER
  • LOCAL RECURRENCE
  • PHASE-III
  • REPRODUCIBILITY
  • CLASSIFICATION
  • RISK
  • PATHOLOGISTS
  • PROLIFERATION
  • AGREEMENT

Cite this

Groen, E. J., Hudecek, J., Mulder, L., van Seijen, M., Almekinders, M. M., Alexov, S., Kovacs, A., Ryska, A., Varga, Z., Navarro, F-J. A., Bianchi, S., Vreuls, W., Balslev, E., Boot, M., Kulka, J., Chmielik, E., Barbe, E., de Rooij, M. J., Vos, W., ... Grand Challenge PRECISION consortium (2020). Prognostic value of histopathological DCIS features in a large-scale international interrater reliability study. Breast Cancer Research and Treatment, 183(3), 759-770. https://doi.org/10.1007/s10549-020-05816-x